HbA1c Testing Market Demand, Business Strategies & Forecast, 2026-2035

Ngày đăng: 24-07-2026 | Ngày cập nhật: 24-07-2026

The HbA1c Testing Market continues to gain momentum as healthcare providers increasingly prioritize early diagnosis and long-term management of diabetes. HbA1c testing has become a cornerstone in diabetes care because it provides a reliable measure of average blood glucose levels over the previous two to three months, enabling physicians to monitor treatment effectiveness and disease progression. Rising diabetes prevalence, growing awareness regarding preventive healthcare, and improvements in diagnostic technologies are accelerating the adoption of HbA1c testing solutions across hospitals, clinics, diagnostic laboratories, and point-of-care settings worldwide.

In 2025, the HbA1c testing market was valued at USD 2.66 Billion. The market is projected to reach USD 6.41 Billion by 2035, expanding at a CAGR of 9.2% during 2026–2035. Increasing investments in healthcare infrastructure, the integration of automated diagnostic platforms, and favorable clinical guidelines supporting routine diabetes screening are expected to strengthen market expansion throughout the forecast period.

North America continues to lead the market owing to its advanced healthcare infrastructure, high diabetes screening rates, and widespread adoption of automated laboratory technologies. Europe remains a significant contributor, supported by government initiatives promoting preventive healthcare and chronic disease management. Asia Pacific is witnessing robust growth due to the increasing diabetic population, expanding healthcare access, rising healthcare expenditures, and growing awareness regarding early disease diagnosis across emerging economies.

From a segmentation perspective, Hospitals & Clinics accounted for a 43.86% share of the HbA1c testing market in 2025, driven by high patient inflow, availability of advanced diagnostic equipment, and integrated diabetes management programs. Meanwhile, Immunoassays captured a 37.51% market share owing to their widespread use in routine diagnostic workflows, high analytical accuracy, and compatibility with automated laboratory systems.

Top Market Trends Transforming the HbA1c Testing Market

Expansion of Point-of-Care HbA1c Testing

Point-of-care (POC) HbA1c testing is becoming increasingly popular as healthcare providers seek rapid diagnostic solutions that deliver immediate clinical insights. Compact analyzers capable of producing laboratory-quality results within minutes are improving patient engagement and enabling physicians to initiate treatment decisions during a single consultation. The growing adoption of decentralized healthcare services and community-based diabetes screening programs is further accelerating demand for portable HbA1c testing systems.

Automation and Digital Laboratory Integration

Clinical laboratories are increasingly implementing fully automated immunoassay and chromatography platforms that improve workflow efficiency while minimizing manual intervention. Integration with laboratory information management systems (LIMS), electronic medical records, and cloud-based reporting solutions enables faster result delivery and enhances diagnostic accuracy. Automation also supports higher testing volumes as healthcare facilities manage increasing numbers of diabetes patients.

Growing Focus on Preventive Healthcare

Governments and healthcare organizations worldwide are placing greater emphasis on preventive healthcare and routine diabetes screening. Clinical guidelines increasingly recommend HbA1c testing for early identification of prediabetes and diabetes, encouraging wider utilization across primary care settings. Public health awareness campaigns and employer-sponsored wellness initiatives are also contributing to higher testing volumes among at-risk populations.

Innovation in Diagnostic Technologies

Manufacturers continue to invest in advanced biosensor technologies, enhanced immunoassays, and improved chromatography systems that offer greater analytical precision and faster turnaround times. Product innovations emphasizing user-friendly operation, reduced sample requirements, and enhanced connectivity are helping healthcare providers improve patient outcomes while reducing operational complexity.

Recent Company Developments

Abbott Laboratories continued expanding its diabetes diagnostics portfolio by strengthening connectivity capabilities and enhancing laboratory automation solutions for chronic disease management.
Roche Diagnostics introduced workflow improvements across its clinical chemistry and immunoassay platforms, supporting faster HbA1c testing and improved laboratory productivity.
Siemens Healthineers enhanced its integrated laboratory solutions by expanding automation capabilities and improving digital healthcare connectivity across diagnostic platforms.
Bio-Rad Laboratories continued investing in high-performance HbA1c quality control products and chromatography systems to improve analytical consistency across laboratories.
Danaher Corporation (Beckman Coulter) expanded diagnostic automation technologies designed to streamline laboratory operations and improve testing efficiency.
Trinity Biotech focused on strengthening its diabetes diagnostics portfolio through continuous product development and improved assay performance for clinical laboratories.
ARKRAY Inc. continued expanding its point-of-care HbA1c analyzers, supporting rapid diabetes diagnosis in hospitals, physician offices, and decentralized healthcare settings.
Sebia strengthened its capillary electrophoresis portfolio with enhanced HbA1c testing capabilities that improve analytical precision and laboratory efficiency.
Tosoh Bioscience continued enhancing its HPLC-based HbA1c analyzers with improved automation features and higher throughput capabilities for large diagnostic laboratories.
EKF Diagnostics expanded accessibility to point-of-care diabetes testing by introducing compact diagnostic solutions designed for primary healthcare and remote clinical settings.

Growth Drivers & Challenge

Growth Driver: Rising Global Diabetes Burden

The continuously increasing prevalence of diabetes remains the primary driver of the HbA1c testing market. Aging populations, sedentary lifestyles, obesity, and changing dietary habits are contributing to a growing number of diabetes cases worldwide. Since HbA1c testing is recognized as a standard diagnostic and monitoring tool for diabetes management, healthcare providers are expanding testing programs to support early diagnosis and long-term patient care.

Growth Driver: Increasing Adoption of Routine Screening Programs

Healthcare systems are increasingly promoting routine screening initiatives for high-risk populations, including individuals with obesity, hypertension, cardiovascular diseases, and family histories of diabetes. These initiatives are encouraging more frequent HbA1c testing, improving disease detection rates, and creating sustained demand for advanced diagnostic technologies across hospitals, clinics, and diagnostic laboratories.

Challenge: Variability Across Testing Methods

Despite significant technological progress, variability among different HbA1c testing methodologies continues to present challenges for healthcare providers. Differences in assay standardization, laboratory calibration, and patient-specific biological factors may influence test accuracy. Continuous quality assurance programs, international standardization efforts, and ongoing technological improvements remain essential for maintaining reliable clinical outcomes.

Regional Analysis

North America

North America maintains its leadership position in the HbA1c testing market due to advanced healthcare infrastructure, favorable reimbursement systems, widespread diabetes screening programs, and high adoption of automated laboratory technologies. Continuous investments in digital healthcare and chronic disease management further support regional market growth.

Europe

Europe continues to demonstrate stable market expansion supported by government healthcare initiatives, strong diagnostic laboratory networks, increasing awareness regarding diabetes prevention, and growing adoption of standardized clinical guidelines for chronic disease monitoring.

Asia Pacific

Asia Pacific represents one of the fastest-growing regional markets due to its rapidly expanding diabetic population, improving healthcare accessibility, increasing healthcare investments, and rising demand for affordable diagnostic solutions. Government-led public health initiatives and expanding diagnostic laboratory infrastructure continue to strengthen regional growth opportunities.

Segmentation Analysis

By End User

Hospitals & Clinics dominated the HbA1c testing market with a 43.86% share in 2025. Their leadership is supported by comprehensive diabetes management services, advanced laboratory capabilities, skilled healthcare professionals, and high patient volumes requiring routine glucose monitoring and disease management.

By Technology

Immunoassays accounted for a 37.51% market share in 2025, benefiting from their broad adoption in routine diagnostic workflows. These systems offer reliable analytical performance, automation compatibility, rapid turnaround times, and efficient integration into high-volume clinical laboratory operations, making them a preferred testing technology across healthcare institutions.

Related Reports

About Fundamental Business Insights

Fundamental Business Insights is a global market research and consulting company engaged in delivering in-depth market intelligence to industrial organizations, financial institutions, universities, non-profit organizations, and corporations. The company provides accurate, timely, and actionable insights that enable informed business decisions through syndicated market research, customized consulting services, and strategic advisory solutions backed by experienced industry consultants.

Contact Us

Robbin Fernandez
Head of Business Development
Fundamental Business Insights and Consulting
Email: sales@fundamentalbusinessinsights.com

Read This Report in Regional Languages -

https://www.fundamentalbusinessinsights.com/ko/industry-report/hba1c-testing-market-20669

https://www.fundamentalbusinessinsights.com/ja/industry-report/hba1c-testing-market-20669

https://www.fundamentalbusinessinsights.com/de/industry-report/hba1c-testing-market-20669

https://www.fundamentalbusinessinsights.com/it/industry-report/hba1c-testing-market-20669

https://www.fundamentalbusinessinsights.com/es/industry-report/hba1c-testing-market-20669

https://www.fundamentalbusinessinsights.com/fr/industry-report/hba1c-testing-market-20669

Trang chủ

Đăng tin miễn phí

Mua Points

Thông báo

Danh mục